Wegovy
Best SellerGLP-1 Weekly Injection

Wegovy

Semaglutide

by Novo Nordisk

Average 21% body weight loss — the gold standard in medically supervised weight loss

From$99.00
HIPAA-compliantUS-licensed physiciansDiscreet delivery
Wegovy medication

21%

Average body weight loss

STEP 1 trial, NEJM 2021

86%

Patients lost ≥5% body weight

STEP 1 trial, NEJM 2021

20%

Reduction in cardiovascular risk

SELECT trial, NEJM 2023

68 weeks

Duration of pivotal clinical trial

STEP 1 trial, NEJM 2021

How It Works

Mechanism of Action

Semaglutide mimics the hormone GLP-1, which is naturally released after eating. It works by slowing gastric emptying, reducing appetite signals in the brain, and improving insulin sensitivity — leading to significant, sustained caloric reduction without the feeling of deprivation.

Dosage Guide

Always follow your prescribing physician's specific instructions. The schedule below is a general guide.

1
Weeks 1–40.25 mg/week

Initiation dose — helps your body adjust, not a therapeutic dose

2
Weeks 5–80.5 mg/week

First escalation — most patients notice appetite reduction

3
Weeks 9–121.0 mg/week

Second escalation — significant weight loss typically begins

4
Weeks 13–161.7 mg/week

Third escalation — continued dose optimisation

5
Week 17+2.4 mg/week

Full maintenance dose — target weekly injection for long-term management

Key Benefits

Once-weekly self-injection — no daily pills
Clinically proven 21% average weight loss
Reduces cardiovascular event risk by 20%
Improves blood sugar control
Reduces blood pressure
Auto-injector pen — easy to use at home
Prescribed & monitored by licensed US physicians

Side Effects

Common Side Effects

  • Nausea (particularly during dose escalation)
  • Diarrhoea
  • Vomiting
  • Constipation
  • Stomach pain
  • Headache
  • Fatigue
  • Dizziness

Rare but Serious

  • Pancreatitis
  • Gallbladder disease
  • Heart rate increase
  • Kidney problems
  • Allergic reactions
  • Suicidal ideation (rare — report immediately)

Seek immediate medical attention if you experience any serious adverse effects.

Frequently Asked Questions

Who Is This For?

  • Adults with BMI ≥30 kg/m²
  • Adults with BMI ≥27 kg/m² with at least one weight-related condition (hypertension, type 2 diabetes, or dyslipidemia)
  • Used alongside a reduced-calorie diet and increased physical activity

Not Suitable For

  • Personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • Pregnancy or breastfeeding
  • Known hypersensitivity to semaglutide

Starting from

$99.00

Reviewed by a licensed US physician

How It Works

1
Complete online consultation
2
Doctor reviews within 24 hrs
3
Prescription issued if approved
4
Discreet home delivery
HIPAA-compliant & secure
US-licensed prescribing physicians
NABP-accredited US pharmacies
SSL encrypted checkout

Ready to Start Your Wegovy Journey?

A licensed US physician will review your consultation, answer all your questions, and prescribe if you're eligible — all from the comfort of home.

No commitment · Reviewed within 24 hours · HIPAA-compliant

Talk with Us